CRISPR Therapeutics

Founded in 2013, CRISPR Therapeutics is a biotechnology research company that has grown from a research-stage gene editing pioneer into a leader in the field, marked by the historic approval of the first-ever CRISPR-based therapy. The company maintains a diverse portfolio of product candidates spanning hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2018, it advanced the first CRISPR/Cas9 gene-edited therapy into clinical trials for sickle cell disease and transfusion-dependent beta thalassemia, culminating in the approval of CASGEVY (exagamglogene autotemcel) in several countries beginning in late 2023. To expand its reach, CRISPR Therapeutics has established strategic partnerships with leading companies such as Vertex Pharmaceuticals. Headquartered at 105 West First Street, Boston, Massachusetts, with additional R&D operations in San Francisco, California, the company employs more than 300 people worldwide.

• 

  CRISPR Therapeutics

  4 days ago

  Research associate ii, oligonucleotide synthesis

  onsite, Boston, MA, United States

  $85k – $92k/yrFull TimeMiddle (2-4 years)

  Apply
• 

  CRISPR Therapeutics

  2 months ago

  Engineer iii, mrna process development-downstream

  onsite, Boston, MA, United States

  $97k – $108k/yrFull TimeMiddle (2-4 years)

  Apply
• 

  CRISPR Therapeutics

  2 months ago

  Scientist ii, crispr-x - gene insertion

  onsite, Boston, MA, United States

  $130k – $140k/yrFull TimeJunior (<2 years)

  Apply
• 

  CRISPR Therapeutics

  2 months ago

  Senior manager, program management

  hybrid, Boston, MA, United States

  $140k – $155k/yrFull TimeSenior (5+ years)

  Apply
• 

  CRISPR Therapeutics

  2 months ago

  Statistical programming contractor (16-month contract)

  hybrid, Boston, MA, United States

  $141k – $161k/yrFull TimeMiddle (2-4 years)

  Apply

Hiring activity at CRISPR Therapeutics